Back
Biomarin Pharmaceutical Stock Predictions
The Next Tech Giant in Your Pocket?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
33
BMRN
Biomarin Pharmaceutical
Last Price:
71.13
Seasonality Move:
5.7%
7 Day Trial
ALL ACCESS PASS
$
7
"EarnPhone": The Investment Hidden in Plain Sight
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Biomarin Pharmaceutical Stock Forecast
- Over the next 52 weeks, Biomarin Pharmaceutical has on average historically risen by 13.3% based on the past 25 years of stock performance.
- Biomarin Pharmaceutical has risen higher in 15 of those 25 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
-
Is Biomarin Pharmaceutical Stock Undervalued?
The current Biomarin Pharmaceutical [BMRN] share price is $71.14. The Score for BMRN is 33, which is 34% below its historic median score of 50, and infers higher risk than normal. - BMRN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Biomarin Pharmaceutical Stock Go Up Next Year?
- Over the next 52 weeks, Biomarin Pharmaceutical has on average historically risen by 13.3% based on the past 25 years of stock performance.
Biomarin Pharmaceutical Stock Rating
Sell
33
Biomarin Pharmaceutical (BMRN)
is a Sell
Is Biomarin Pharmaceutical overpriced?
- Biomarin Pharmaceutical has risen higher in 15 of those 25 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
Biomarin Pharmaceutical Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
biomarin.com
52-Week Data
52-Week High:
99.56
52-Week Low:
68.83
Prediction Charts
Market Cap:
13.54B
Price in USD:
71.14
Volume:
2.17M
Beta:
0.88
Technical Analysis
SMA50:
85.93
SMA100:
83.43
SMA200:
87.02
52-Wk Change:
-19.71%
Stock Predictions
-
Is Biomarin Pharmaceutical stock public?
Yes, Biomarin Pharmaceutical is a publicly traded company. -
What is the Biomarin Pharmaceutical stock quote today?
The Biomarin Pharmaceutical stock price is 71.14 USD today. -
How to buy Biomarin Pharmaceutical stock online?
You can buy Biomarin Pharmaceutical shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Aug-29 | 90.60 | 91.37 | 93.04 | 90.29 |
| Aug-30 | 91.46 | 91.17 | 92.35 | 89.95 |
| Sep-3 | 91.21 | 91.61 | 92.81 | 90.85 |
| Sep-4 | 91.19 | 89.86 | 92.05 | 87.68 |
| Sep-5 | 90.01 | 85.13 | 90.01 | 84.89 |
| Sep-6 | 85.33 | 84.11 | 86.04 | 83.73 |
| Sep-9 | 84.28 | 84.35 | 84.84 | 83.45 |
| Sep-10 | 84.48 | 84.85 | 85.64 | 83.69 |
| Sep-11 | 84.72 | 84.76 | 84.94 | 83.43 |
| Sep-12 | 84.83 | 84.35 | 85.00 | 83.91 |
| Sep-13 | 84.43 | 84.90 | 85.00 | 83.95 |
| Sep-16 | 77.53 | 69.86 | 78.00 | 69.60 |
| Sep-17 | 70.00 | 70.55 | 71.64 | 68.83 |
| Sep-18 | 70.87 | 71.14 | 71.58 | 70.11 |
Biomarin Pharmaceutical Earnings
Biomarin Pharmaceutical Earnings Report: Per Share Biomarin Pharmaceutical Earnings Q1 Q2 Q3 and Q4 last year and next year.
Biomarin Pharmaceutical Forecast Revenue Growth
Biomarin Pharmaceutical Stock Analysis: Historical quarterly revenues per share for Biomarin Pharmaceutical and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.31 per share, an increase next quarter of $0.29 per share, an increase this year of $1.19 per share, and an increase next year of $1.04 per share.
* Biomarin Pharmaceutical stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.